Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Grows By 26.9%

Coloplast A/S (OTCMKTS:CLPBY) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 77,000 shares, an increase of 26.9% from the February 13th total of 60,700 shares. Based on an average daily volume of 268,300 shares, the short-interest ratio is currently 0.3 days.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CLPBY. Royal Bank of Canada raised shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a report on Monday, March 3rd. Sanford C. Bernstein raised shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th.

Coloplast A/S Stock Down 0.1 %

Shares of CLPBY stock opened at $10.61 on Wednesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.02 and a quick ratio of 0.66. Coloplast A/S has a 1-year low of $10.43 and a 1-year high of $14.14. The firm has a fifty day moving average of $11.06 and a two-hundred day moving average of $12.05.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. On average, sell-side analysts anticipate that Coloplast A/S will post 0.31 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.